Thursday, December 11, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

“Learn, unlearn, relearn”

IPN by IPN
20 October 2020
in News
0
“Learn, unlearn, relearn”
Previous Post

Ear Care Management in Pharmacy

 Next Post

Musculoskeletal Conditions and Pain
Next Post
Musculoskeletal Conditions and Pain

Musculoskeletal Conditions and Pain

Migraine Ireland launches the Irish Headache Society to advance migraine and headache care in Ireland.

Migraine Ireland Launches First Multidisciplinary Irish Headache Society

8 December 2025
Boots Ireland launches Common Conditions Service allowing pharmacists to prescribe for the first time.

Boots Ireland Unveils Groundbreaking Common Conditions Service, Empowering Pharmacists to Prescribe for the First Time

8 December 2025
Back to school: Expert guidance from the HSE for a smoother start to the school year

Pharmacy Regulator welcomes launch of training for pharmacists to support roll-out of new Common Conditions Service to the public

20 November 2025

RECOMMENDED NEWS

United Drug Business Development Independent Award 2023

United Drug Business Development Independent Award 2023

3 years ago
RCSI ranked as world number one for ‘Good Health and Well-being’ in THE University Impact Rankings

RCSI ranked as world number one for ‘Good Health and Well-being’ in THE University Impact Rankings

6 months ago
New Safety Data Suggests Esketamine Nasal Spray is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder1,2

New Safety Data Suggests Esketamine Nasal Spray is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder1,2

2 years ago
Zinc, immunity and the common cold

Zinc, immunity and the common cold

5 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN